Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling.
Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling.
复制标题
DOI：
10.1016/j.phymed.2022.154444
复制
发表时间：
2022-09
期刊：
影响因子：
--
通讯作者：
Yuanyuan Zhai;Wenling Zhou;Xuejing Yan;Yuan Qiao;Lingling Guan;Zhichun Zhang;H. Liu;Jizhi Jiang-Ji
中科院分区：
文献类型：
--
作者：
Yuanyuan Zhai;Wenling Zhou;Xuejing Yan;Yuan Qiao;Lingling Guan;Zhichun Zhang;H. Liu;Jizhi Jiang-Ji
